1 employees
Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins.
2005
$4.5M
from 2 investors over 2 rounds
ALGENEX-Alternative Gen Expression S.L. raised $4.5M on March 6, 2019
Investors: Cleon Capital Advisors and Vita